Previous close | 19.71 |
Open | 19.94 |
Bid | 19.12 x 1800 |
Ask | 20.25 x 900 |
Day's range | 19.40 - 19.94 |
52-week range | 17.24 - 26.56 |
Volume | |
Avg. volume | 244,716 |
Market cap | 903.389M |
Beta (5Y monthly) | 0.96 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
Avanos Medical ( NYSE:AVNS ) First Quarter 2024 Results Key Financial Results Revenue: US$166.1m (up 4.3% from 1Q...
Avanos Medical (AVNS) delivered earnings and revenue surprises of +4.76% and 1.65%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?